ACS Nano (IF=16.0): Computer-Guided Discovery of Polysaccharide Derivatives as Adjuvants for Cancer Immunotherapy Nanoparticle Vaccines
This article is reprinted from “Pharmaceutical Targeting“ Adjuvants are key components of many vaccines, enhancing the immunogenicity of antigens by improving the intensity, breadth, quality, and duration of the immune response. Since the approval of aluminum-based adjuvants by the U.S. Food and Drug Administration in 1939, the development of new adjuvants has progressed relatively slowly. … Read more